You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 29, 2024

~ Buy the PROMACTA (eltrombopag olamine) Drug Profile, 2024 PDF Report in the Report Store ~

Drug Price Trends for promacta


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for promacta

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
PROMACTA 25 MG, POWD PACK Novartis Pharmaceuticals Corporation 00078-0697-61 30 5950.90 198.36333 EACH 2023-01-01 - 2025-08-31 FSS
PROMACTA 50MG TAB Novartis Pharmaceuticals Corporation 00078-0686-15 30 9952.54 331.75133 EACH 2022-01-01 - 2025-08-31 FSS
PROMACTA 50MG TAB Novartis Pharmaceuticals Corporation 00078-0686-55 14 4944.78 353.19857 EACH 2024-01-01 - 2025-08-31 FSS
PROMACTA 12.5MG TAB Novartis Pharmaceuticals Corporation 00078-0684-15 30 4427.26 147.57533 EACH 2023-01-01 - 2025-08-31 Big4
PROMACTA 25 MG, POWD PACK Novartis Pharmaceuticals Corporation 00078-0697-61 30 3945.58 131.51933 EACH 2020-09-30 - 2025-08-31 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.